Boc-Lys(Tos)-ONp

Boc-Lys(Tos)-ONp is a protected lysine derivative bearing a tert-butoxycarbonyl (Boc) group on the α-amino position, a tosyl (Tos) protecting group on the ε-amino side chain, and an active ONp ester (p-nitrophenyl ester) at the carboxylate. This combination makes the compound a practical amino acid building block for peptide and amide bond formation, where the ONp leaving group supports efficient coupling under standard peptide synthesis conditions. Researchers commonly select this specific protection pattern to control chemoselectivity during stepwise assembly of lysine-containing sequences and to minimize side reactions from the ε-amino functionality.

1. Peptide Coupling Building Block

Boc-Lys(Tos)-ONp is used as an activated lysine building block in peptide synthesis workflows, especially when forming amide bonds via ONp ester chemistry to generate lysine-containing segments with controlled functional-group protection. Peptide chemists rely on the Boc/Tos protection pattern to keep both the α-amino and ε-amino functionalities masked during coupling, allowing sequential assembly without premature ε-amino participation. The ONp ester format is particularly useful for preparing peptide intermediates where a reliable activated carboxylate is required for downstream condensation steps, including the preparation of protected peptide fragments for custom peptide manufacturing and library synthesis.

2. Lysine-Containing Fragment Assembly

Boc-Lys(Tos)-ONp supports the construction of protected peptide fragments in solution-phase or mixed synthesis strategies, where lysine residues must remain fully protected until the intended deprotection stage. In segment condensation approaches, the activated ONp ester enables coupling to an appropriately protected nucleophile (such as a protected amine on another fragment), facilitating efficient formation of the peptide bond while preserving the lysine side chain as the Tos-protected ε-amino group. This makes the reagent a common choice in laboratories that assemble multi-residue constructs requiring consistent lysine handling, including the preparation of peptide standards, reference fragments for method development, and intermediate materials used in longer sequence assembly.

3. Pharmaceutical Intermediate Development

Boc-Lys(Tos)-ONp is frequently employed in pharmaceutical intermediate development when lysine-based protected amide linkages are needed as part of larger synthesis programs, such as the assembly of peptidomimetic scaffolds or protected lysine-containing intermediates. The presence of Boc and Tos protecting groups helps ensure that only the intended coupling site reacts during intermediate formation, which is valuable for controlling selectivity in multi-step routes. The ONp ester activation provides a practical handle for forming defined amide bonds prior to later functional-group transformations, supporting the creation of well-characterized, protected intermediates used in downstream synthetic elaboration.

4. Protected Amide Bond Synthesis

Boc-Lys(Tos)-ONp also serves as a specialized activated amino acid derivative for forming protected amide bonds beyond strictly peptide-only contexts, including the preparation of lysine-derived linkers and protected conjugation precursors where the ε-amino group must remain masked. Chemists use the ONp ester to promote coupling to amine nucleophiles while maintaining the lysine side chain protection, which is essential when downstream steps require orthogonal deprotection or controlled functionalization. This application is particularly relevant in chemical biology and materials-oriented synthesis planning, where lysine-containing building blocks are incorporated into larger constructs under protection schemes designed to prevent undesired cross-reactions.

1. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

3. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

4. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment